Evaluation of Serum Preptin Levels in Patients With Polycystic Ovary Syndrome

Sex: Female

Ages: 18 Years – 45 Years

Healthy volunteers: No

Enrollment: 60

Sponsor: GÜLDEN ANATACA

Summary

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age and is strongly associated with insulin resistance and metabolic dysfunction. Preptin is a pancreatic peptide co-secreted with insulin and has been implicated in glucose metabolism and insulin resistance. However, limited data exist regarding serum preptin levels in patients with PCOS. The aim of this study is to evaluate serum preptin levels in women diagnosed with PCOS and to investigate the relationship between preptin levels and insulin resistance parameters.

Eligibility Criteria

Inclusion Criteria: * Female participants aged 18-45 years * Diagnosis of PCOS according to Rotterdam criteria * BMI \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07736079). StuddyBuddy aggregates publicly available trial information.